Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
167%(5 trials)
Terminated
2(40%)

Phase Distribution

Ph phase_2
4
80%
Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
60.0%
Most Advanced
Phase 2

Trials by Phase

Phase 24 (80.0%)
N/A1 (20.0%)

Trials by Status

completed360%
terminated240%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_2

Therapy for Children With Advanced Stage Neuroblastoma

NCT01857934
completedphase_2

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

NCT01700946
terminatedphase_2

Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma

NCT00698009
terminatedphase_2

Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer

NCT00376805
completednot_applicable

Natural Killer (NK) Cell Transplantation for AML

NCT00187096

Clinical Trials (5)

Showing 5 of 5 trials
NCT01857934Phase 2

Therapy for Children With Advanced Stage Neuroblastoma

Completed
NCT01700946Phase 2

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

Completed
NCT00698009Phase 2

Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma

Terminated
NCT00376805Phase 2

Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer

Terminated
NCT00187096Not Applicable

Natural Killer (NK) Cell Transplantation for AML

Completed

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5